1. Home
  2. ITRI vs BBIO Comparison

ITRI vs BBIO Comparison

Compare ITRI & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRI
  • BBIO
  • Stock Information
  • Founded
  • ITRI 1977
  • BBIO 2015
  • Country
  • ITRI United States
  • BBIO United States
  • Employees
  • ITRI N/A
  • BBIO N/A
  • Industry
  • ITRI Electrical Products
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITRI Industrials
  • BBIO Health Care
  • Exchange
  • ITRI Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • ITRI 4.9B
  • BBIO 5.1B
  • IPO Year
  • ITRI 1993
  • BBIO 2019
  • Fundamental
  • Price
  • ITRI $110.45
  • BBIO $28.53
  • Analyst Decision
  • ITRI Buy
  • BBIO Strong Buy
  • Analyst Count
  • ITRI 11
  • BBIO 13
  • Target Price
  • ITRI $124.90
  • BBIO $48.33
  • AVG Volume (30 Days)
  • ITRI 424.4K
  • BBIO 2.0M
  • Earning Date
  • ITRI 10-31-2024
  • BBIO 11-12-2024
  • Dividend Yield
  • ITRI N/A
  • BBIO N/A
  • EPS Growth
  • ITRI 197.28
  • BBIO N/A
  • EPS
  • ITRI 4.87
  • BBIO N/A
  • Revenue
  • ITRI $2,405,146,000.00
  • BBIO $217,765,000.00
  • Revenue This Year
  • ITRI $14.14
  • BBIO $2,306.97
  • Revenue Next Year
  • ITRI $1.17
  • BBIO N/A
  • P/E Ratio
  • ITRI $22.69
  • BBIO N/A
  • Revenue Growth
  • ITRI 16.53
  • BBIO 2209.77
  • 52 Week Low
  • ITRI $67.21
  • BBIO $21.62
  • 52 Week High
  • ITRI $124.90
  • BBIO $44.32
  • Technical
  • Relative Strength Index (RSI)
  • ITRI 42.82
  • BBIO 59.15
  • Support Level
  • ITRI $106.95
  • BBIO $25.34
  • Resistance Level
  • ITRI $109.89
  • BBIO $28.15
  • Average True Range (ATR)
  • ITRI 3.08
  • BBIO 1.33
  • MACD
  • ITRI -0.72
  • BBIO -0.08
  • Stochastic Oscillator
  • ITRI 31.67
  • BBIO 68.60

About ITRI Itron Inc.

Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: